GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk

A case-control study

Angela Zupa, Alessandro Sgambato, Gabriella Bianchino, Giuseppina Improta, Vitina Grieco, Giuseppe La Torre, Biagina Campisi, Antonio Traficante, Michele Aieta, Achille Cittadini

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Glutathione S-transferase M1 (GSTM1) and N-acetyltransferase-2 (NAT2) are phase II enzymes involved in the metabolism of xenobiotics and whose polymorphisms have been related to individual cancer risks. Patients and Methods: A case-control study was performed including 92 colon, 75 lung and 23 bladder cancer patients and 121 corresponding controls to verify the existence of an association between the main genetic polymorphisms of GSTM1 and NAT2 and the risk to develop cancer. Genomic DNA, isolated from 5 mL whole blood, was used to study GSTM1 and NAT2 polymorphisms using multiplex PCR and a PCR-RFLP technique, respectively. Results: GSTM1 homozygous null genotype was associated with an increased risk of colon cancer, especially in females and in younger patients. For NAT2 gene, the results suggest a role for the low acetylator phenotype in the development of colon and lung cancer, especially in females. In bladder cancer patients two rare NAT2 genotypes were found at a higher frequency compared with all the other groups. Conclusion: The results do not suggest a different distribution of GSTM1 and NAT2 polymorphisms in the studied population compared to those reported for other Caucasian populations and warrant further studies in order to evaluate their potential relationship with individual cancer risks.

Original languageEnglish
Pages (from-to)1709-1714
Number of pages6
JournalAnticancer Research
Volume29
Issue number5
Publication statusPublished - May 2009

Fingerprint

Acetyltransferases
Urinary Bladder Neoplasms
Colonic Neoplasms
Case-Control Studies
Lung Neoplasms
Genotype
Neoplasms
Multiplex Polymerase Chain Reaction
Xenobiotics
Genetic Polymorphisms
Restriction Fragment Length Polymorphisms
Population
glutathione S-transferase M1
Colon
Phenotype
Polymerase Chain Reaction
Lung
DNA
Enzymes
Genes

Keywords

  • Cancer susceptibility
  • Gene polymorphisms
  • Southern Italian region
  • Tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Zupa, A., Sgambato, A., Bianchino, G., Improta, G., Grieco, V., La Torre, G., ... Cittadini, A. (2009). GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: A case-control study. Anticancer Research, 29(5), 1709-1714.

GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk : A case-control study. / Zupa, Angela; Sgambato, Alessandro; Bianchino, Gabriella; Improta, Giuseppina; Grieco, Vitina; La Torre, Giuseppe; Campisi, Biagina; Traficante, Antonio; Aieta, Michele; Cittadini, Achille.

In: Anticancer Research, Vol. 29, No. 5, 05.2009, p. 1709-1714.

Research output: Contribution to journalArticle

Zupa, A, Sgambato, A, Bianchino, G, Improta, G, Grieco, V, La Torre, G, Campisi, B, Traficante, A, Aieta, M & Cittadini, A 2009, 'GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: A case-control study', Anticancer Research, vol. 29, no. 5, pp. 1709-1714.
Zupa A, Sgambato A, Bianchino G, Improta G, Grieco V, La Torre G et al. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: A case-control study. Anticancer Research. 2009 May;29(5):1709-1714.
Zupa, Angela ; Sgambato, Alessandro ; Bianchino, Gabriella ; Improta, Giuseppina ; Grieco, Vitina ; La Torre, Giuseppe ; Campisi, Biagina ; Traficante, Antonio ; Aieta, Michele ; Cittadini, Achille. / GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk : A case-control study. In: Anticancer Research. 2009 ; Vol. 29, No. 5. pp. 1709-1714.
@article{6fd1f3233c184072b6228cb1e755b17f,
title = "GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: A case-control study",
abstract = "Background: Glutathione S-transferase M1 (GSTM1) and N-acetyltransferase-2 (NAT2) are phase II enzymes involved in the metabolism of xenobiotics and whose polymorphisms have been related to individual cancer risks. Patients and Methods: A case-control study was performed including 92 colon, 75 lung and 23 bladder cancer patients and 121 corresponding controls to verify the existence of an association between the main genetic polymorphisms of GSTM1 and NAT2 and the risk to develop cancer. Genomic DNA, isolated from 5 mL whole blood, was used to study GSTM1 and NAT2 polymorphisms using multiplex PCR and a PCR-RFLP technique, respectively. Results: GSTM1 homozygous null genotype was associated with an increased risk of colon cancer, especially in females and in younger patients. For NAT2 gene, the results suggest a role for the low acetylator phenotype in the development of colon and lung cancer, especially in females. In bladder cancer patients two rare NAT2 genotypes were found at a higher frequency compared with all the other groups. Conclusion: The results do not suggest a different distribution of GSTM1 and NAT2 polymorphisms in the studied population compared to those reported for other Caucasian populations and warrant further studies in order to evaluate their potential relationship with individual cancer risks.",
keywords = "Cancer susceptibility, Gene polymorphisms, Southern Italian region, Tumorigenesis",
author = "Angela Zupa and Alessandro Sgambato and Gabriella Bianchino and Giuseppina Improta and Vitina Grieco and {La Torre}, Giuseppe and Biagina Campisi and Antonio Traficante and Michele Aieta and Achille Cittadini",
year = "2009",
month = "5",
language = "English",
volume = "29",
pages = "1709--1714",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk

T2 - A case-control study

AU - Zupa, Angela

AU - Sgambato, Alessandro

AU - Bianchino, Gabriella

AU - Improta, Giuseppina

AU - Grieco, Vitina

AU - La Torre, Giuseppe

AU - Campisi, Biagina

AU - Traficante, Antonio

AU - Aieta, Michele

AU - Cittadini, Achille

PY - 2009/5

Y1 - 2009/5

N2 - Background: Glutathione S-transferase M1 (GSTM1) and N-acetyltransferase-2 (NAT2) are phase II enzymes involved in the metabolism of xenobiotics and whose polymorphisms have been related to individual cancer risks. Patients and Methods: A case-control study was performed including 92 colon, 75 lung and 23 bladder cancer patients and 121 corresponding controls to verify the existence of an association between the main genetic polymorphisms of GSTM1 and NAT2 and the risk to develop cancer. Genomic DNA, isolated from 5 mL whole blood, was used to study GSTM1 and NAT2 polymorphisms using multiplex PCR and a PCR-RFLP technique, respectively. Results: GSTM1 homozygous null genotype was associated with an increased risk of colon cancer, especially in females and in younger patients. For NAT2 gene, the results suggest a role for the low acetylator phenotype in the development of colon and lung cancer, especially in females. In bladder cancer patients two rare NAT2 genotypes were found at a higher frequency compared with all the other groups. Conclusion: The results do not suggest a different distribution of GSTM1 and NAT2 polymorphisms in the studied population compared to those reported for other Caucasian populations and warrant further studies in order to evaluate their potential relationship with individual cancer risks.

AB - Background: Glutathione S-transferase M1 (GSTM1) and N-acetyltransferase-2 (NAT2) are phase II enzymes involved in the metabolism of xenobiotics and whose polymorphisms have been related to individual cancer risks. Patients and Methods: A case-control study was performed including 92 colon, 75 lung and 23 bladder cancer patients and 121 corresponding controls to verify the existence of an association between the main genetic polymorphisms of GSTM1 and NAT2 and the risk to develop cancer. Genomic DNA, isolated from 5 mL whole blood, was used to study GSTM1 and NAT2 polymorphisms using multiplex PCR and a PCR-RFLP technique, respectively. Results: GSTM1 homozygous null genotype was associated with an increased risk of colon cancer, especially in females and in younger patients. For NAT2 gene, the results suggest a role for the low acetylator phenotype in the development of colon and lung cancer, especially in females. In bladder cancer patients two rare NAT2 genotypes were found at a higher frequency compared with all the other groups. Conclusion: The results do not suggest a different distribution of GSTM1 and NAT2 polymorphisms in the studied population compared to those reported for other Caucasian populations and warrant further studies in order to evaluate their potential relationship with individual cancer risks.

KW - Cancer susceptibility

KW - Gene polymorphisms

KW - Southern Italian region

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=67650093556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650093556&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 1709

EP - 1714

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -